Hans Edgar Bishop - 05 Apr 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director
Signature
/s/ Bernard J. Cassidy, Attorney-in-Fact for Hans Edgar Bishop
Issuer symbol
SANA
Transactions as of
05 Apr 2023
Net transactions value
$0
Form type
4
Filing time
06 Apr 2023, 16:45:17 UTC
Previous filing
20 Mar 2023
Next filing
09 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Award $0 +7,716 +0.13% $0.000000 5,760,888 05 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested restricted stock units for which the Reporting Person has elected to defer settlement until January 1, 2024 pursuant to Sana Biotechnology, Inc.'s Non-Employee Director Compensation Program.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney